Best Researcher Award
Rehab Elmeazawy, Tanta University
The Best Researcher Award recognizes distinguished scholarly achievements and sustained scientific contributions in the field of infectious diseases and pediatric respiratory research. Rehab Elmeazawy of Tanta University has demonstrated a growing academic profile through peer-reviewed publications, collaborative research initiatives, and contributions to the understanding of pediatric pneumonia and related infectious disease challenges.[1]
Abstract
Rehab Elmeazawy is associated with academic and clinical research focused on pediatric pneumonia and infectious disease management. The researcher’s scholarly activities contribute to the growing body of evidence supporting improved diagnostic, preventive, and therapeutic strategies in pediatric infectious diseases. Through peer-reviewed scientific output and institutional collaboration, the research profile demonstrates engagement in medically relevant investigations with implications for healthcare quality and patient outcomes.[1]
Keywords
Pediatric Pneumonia, Infectious Diseases, Clinical Research, Respiratory Infections, Pediatric Healthcare, Scientific Publications, Epidemiology, Academic Research, Evidence-Based Medicine, Medical Research Awards
Introduction
Pediatric pneumonia remains one of the leading infectious causes of morbidity and mortality among children worldwide. Continued scientific inquiry into diagnosis, prevention, and therapeutic management is essential for improving clinical outcomes and strengthening public health systems. Researchers contributing to this area provide valuable insights that support healthcare policy, clinical practice, and patient-centered interventions.[3]
Research Profile
The academic profile of Rehab Elmeazawy includes indexed scholarly publications and measurable citation activity within the Scopus database. With an h-index reflecting cited contributions and a portfolio of scientific documents, the researcher demonstrates active engagement in academic dissemination and collaborative medical research.[1]
- Affiliated with Tanta University, Egypt
- Research specialization in Pediatric Pneumonia and infectious diseases
Research Contributions
The research contributions associated with Rehab Elmeazawy primarily address clinical and pediatric infectious disease concerns, particularly within the context of respiratory infections. Scientific work in this field supports evidence-based approaches to diagnosis, treatment optimization, and disease prevention strategies among pediatric populations.[3]
Publications
The publication record indexed under the Scopus Author ID 57914576300 includes scientific documents relevant to pediatric healthcare and infectious disease investigations. Publications contribute to ongoing medical discourse regarding pediatric respiratory conditions and related clinical management practices.[1]
- Research studies related to pediatric pneumonia diagnosis and treatment methodologies.
- Clinical investigations examining infectious disease patterns among pediatric populations.
Research Impact
The measurable research indicators associated with Rehab Elmeazawy demonstrate emerging scholarly visibility through citations and indexed publications. Citation metrics and academic indexing provide insight into the reach and relevance of scientific contributions within the medical research community.[1]
Award Suitability
The research profile of Rehab Elmeazawy aligns with the objectives of the International Research Awards on Infectious Diseases by demonstrating scholarly engagement in infectious disease and pediatric healthcare research. Indexed publications, citation activity, and institutional affiliation collectively support consideration for academic recognition within the field.[2]
- Documented scientific publication record
- Research relevance to pediatric infectious diseases
Conclusion
Rehab Elmeazawy represents an emerging academic contributor within the field of pediatric pneumonia and infectious disease research. Through scholarly publications, institutional engagement, and measurable research metrics, the researcher demonstrates ongoing commitment to advancing scientific understanding and supporting evidence-based healthcare practices. The academic profile aligns with the objectives of international research recognition initiatives dedicated to infectious disease innovation and clinical impact.[1]
External Links
References
- Elsevier. (n.d.). Scopus author details: Rehab Elmeazawy, Author ID 57914576300. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57914576300
- Ragab, S. A., Razik, A. A., Sharaby, R. E., & Elmeazawy, R. Iron status and anemia as predictors for acute bronchiolitis severity.
https://link.springer.com/article/10.1186/s43168-024-00316-8
- Elmeazawy, R., Ayoub, D., Morad, L. M., & El-Moazen, A. M. F. Role of systemic immune-inflammatory index and systemic inflammatory response index in predicting the diagnosis of necrotizing pneumonia in children.
https://pubmed.ncbi.nlm.nih.gov/39095744/
- Elmeazawy, R., & El Amrousy, D. Baseline characteristics and analysis of predictors of the outcome of septic pulmonary embolism in children: a retrospective observational study.
https://link.springer.com/article/10.1186/s12887-023-03998-z
- Elmeazawy, R., AbdElsamea, M. Z., Elaskary, E. M., & Emara, M. H. Diagnostic performance of lung ultrasound for detecting lung necrosis in children with community-acquired pneumonia.
https://www.nature.com/articles/s41390-026-05026-z